Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: a retrospective cohort study.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of clinical neuroscience

• Publication date

  2008-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jocn.2007.02.095PMID 18343119
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease

  2006cited by this paper
• Nonsteroidal anti‐inflammatory drugs and risk of Parkinson's disease

  2006cited by this paper
• Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease

  2005cited by this paper
• Oxidative stress and inflammation in Parkinson's disease: is there a causal link?

  2005cited by this paper
• Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations

  2004cited by this paper
• Inflammation and neurodegeneration in Parkinson's disease.

  2004cited by this paper
• Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.

  2003cited by this paper

• Rheumatoid arthritis drugs and the risk of Parkinson’s disease – a meta-analysis

  2025cites this paper
• GDF15 upregulation in Parkinson's disease: Compensatory mechanisms and causal insights.

  2025cites this paper
• Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery

  2024cites this paper
• Neuroinflammation-induced neurodegeneration and associated microglia activation in Parkinson’s disease: a novel neurotherapeutic avenue

  2024influential citation
• The relation between Parkinson’s disease and non-steroidal anti-inflammatories; a systematic review and meta-analysis

  2024cites this paper
• A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson’s disease: beneficial or detrimental effects

  2023cites this paper
• Novel Applications of NSAIDs: Insight and Future Perspectives in Cardiovascular, Neurodegenerative, Diabetes and Cancer Disease Therapy

  2021cites this paper
• Exploring the molecular approach of COX and LOX in Alzheimer’s and Parkinson’s disorder

  2020cites this paper
• Preventive treatments to slow substantia nigra damage and Parkinson's disease progression: a critical perspective review.

  2020cites this paper
• Risk of Multiple System Atrophy and the Use of Anti-Inflammatory Drugs: A Danish Register-Based Case-Control Study

  2019cites this paper
• Mechanism underlying β2-AR agonist-mediated phenotypic conversion of LPS-activated microglial cells.

  2019cites this paper
• Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson's Disease.

  2019cites this paper
• Non-steroidal anti-inflammatory drugs and risk of Parkinson’s disease in the elderly population: a meta-analysis

  2018cites this paper
• Nonsteroidal anti-inflammatory drugs use and risk of Parkinson disease

  2018influential citation
• Oxidative stress and neuroinflammation in the story of Parkinson’s disease: Could targeting these pathways write a good ending?

  2018cites this paper
• Updates on immunity and inflammation in Parkinson disease pathology

  2018cites this paper
• The use of non-steroidal anti-inflammatory drugs in neurological diseases.

  2017cites this paper
• An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition

  2017cites this paper
• Neuroprotective and immunomodulatory effects of raloxifene in the myenteric plexus of a mouse model of Parkinson's disease.

  2016cites this paper
• Design of reprogrammed neuronal transplantation and nanobiomaterial-based microglial therapeutic technologies for management of Parkinson's disease

  2016cites this paper
• Cell-Type Specific Actions of Inflammatory Mediators in the CNS

  2016cites this paper
• Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity.

  2016cites this paper
• Ibuprofen in Prevention of Neurodegenerative Diseases

  2015cites this paper
• Neuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugs.

  2015cites this paper
• Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies

  2015cites this paper
• PET radioligands for in vivo visualization of neuroinflammation.

  2014cites this paper
• Evidence of Inflammatory System Involvement in Parkinson's Disease

  2014cites this paper
• Neural and Immune Mechanisms in the Pathogenesis of Parkinson’s Disease

  2013cites this paper
• Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity

  2013cites this paper
• Microglial Phenotype and Adaptation

  2013cites this paper
• The Role of Inflammatory and Oxidative Stress Mechanisms in the Pathogenesis of Parkinson’s Disease: Focus on Astrocytes

  2013cites this paper
• Sodium salicylate protects against rotenone‐induced Parkinsonism in rats

  2013cites this paper
• EFEITO TIPO-ANTIDEPRESSIVO E ANTIOXIDANTE DO IBUPROFENO NO MODELO DA DOENÇA DE PARKINSON INDUZIDO POR ADMINISTRAÇÃO DE ROTENONA INTRAPERITONEAL EM RATOS

  2013influential citation
• POPULATION-BASED EVALUATION OF TWO REGIMENS FOR EMERGENCY CONTRACEPTION: A PHARMACOEPIDEMIOLOGIC STUDY

  2012cites this paper
• The Hsp 70 Chaperone System in Parkinson ’ s Disease

  2012cites this paper
• The Hsp70 Chaperone System in Parkinson’s Disease

  2011cites this paper
• Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies.

  2011cites this paper
• NSAID use and risk of Parkinson disease: a population‐based case‐control study

  2011cites this paper
• Use of ibuprofen and risk of Parkinson disease

  2011cites this paper
• Licofelone attenuates MPTP-induced neuronal toxicity: behavioral, biochemical and cellular evidence

  2010cites this paper
• Diverse methyl sulfone-containing benzo[b]thiophene library via iodocyclization and palladium-catalyzed coupling.

  2010cites this paper
• Risk for Parkinson's disease among patients with osteoarthritis: A Danish cohort study

  2010cites this paper
• Anti-inflammatory drugs and risk of Parkinson disease

  2010cites this paper
• Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra

  2010cites this paper
• Microglia and neuroprotection: from in vitro studies to therapeutic applications.

  2010cites this paper
• Inflammatory Mechanisms of Neurodegeneration in Toxin-Based Models of Parkinson's Disease

  2010cites this paper
• Cyclooxygenase and Neuroinflammation in Parkinson’s Disease Neurodegeneration

  2010cites this paper
• Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation

  2010cites this paper
• The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research.

  2009cites this paper
• Kinetics of Microglial Activation and Degeneration of Dopamine-Containing Neurons in a Rat Model of Parkinson Disease Induced by 6-Hydroxydopamine

  2009cites this paper
• NSAID Use and the Risk of Parkinson’s Disease

  2009cites this paper
• Protective effect of cyclooxygenase (COX)-inhibitors against drug-induced catatonia and MPTP-induced striatal lesions in rats.

  2009cites this paper
• Catalytic Antioxidants and Neurodegeneration

  2009cites this paper
• Autoimmune disease and risk for Parkinson disease

  2009cites this paper
• JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.

  2009cites this paper
• Place de l'activation microgliale associée à la dégénérescence des neurones dopaminergiques provoquée par la 6-OHDA chez le rat : implication dans la compréhension de la pathogénie de la maladie de Parkinson

  2008cites this paper
• Statin use and the risk of Parkinson disease: a nested case control study.

  2008cites this paper
• NSAID use and the risk of Parkinson's disease.

  2006cites this paper